Christopher Twelves

2.3k total citations
53 papers, 1.3k citations indexed

About

Christopher Twelves is a scholar working on Oncology, Cancer Research and Molecular Biology. According to data from OpenAlex, Christopher Twelves has authored 53 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 34 papers in Oncology, 14 papers in Cancer Research and 11 papers in Molecular Biology. Recurrent topics in Christopher Twelves's work include Cancer Treatment and Pharmacology (20 papers), Breast Cancer Treatment Studies (9 papers) and Advanced Breast Cancer Therapies (8 papers). Christopher Twelves is often cited by papers focused on Cancer Treatment and Pharmacology (20 papers), Breast Cancer Treatment Studies (9 papers) and Advanced Breast Cancer Therapies (8 papers). Christopher Twelves collaborates with scholars based in United Kingdom, United States and Canada. Christopher Twelves's co-authors include Helen Mackay, John M.S. Bartlett, Alison F. Munro, Michael J. O’Connell, Daniel G. Haller, Greg Yothers, Daniel J. Sargent, Leonard B. Saltz, Dana Faratian and Nadine J. McCleary and has published in prestigious journals such as Journal of Clinical Oncology, Nature reviews. Cancer and Cancer Research.

In The Last Decade

Christopher Twelves

53 papers receiving 1.3k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Christopher Twelves United Kingdom	18	630	467	205	150	139	53	1.3k
Ken Ohmine Japan	21	528 0.8×	605 1.3×	124 0.6×	73 0.5×	119 0.9×	82	1.4k
Antje Lebrecht Germany	23	610 1.0×	407 0.9×	305 1.5×	147 1.0×	215 1.5×	58	1.4k
Man‐Hsin Hung Taiwan	21	488 0.8×	537 1.1×	232 1.1×	273 1.8×	214 1.5×	45	1.4k
Chung-Tsen Hsueh United States	19	556 0.9×	416 0.9×	200 1.0×	305 2.0×	87 0.6×	55	1.2k
Rebecca Marnocha United States	17	476 0.8×	726 1.6×	203 1.0×	260 1.7×	208 1.5×	35	1.3k
Kiyoshi Okamoto Japan	15	514 0.8×	611 1.3×	267 1.3×	331 2.2×	100 0.7×	55	1.7k
John K. Leighton United States	18	463 0.7×	670 1.4×	150 0.7×	148 1.0×	131 0.9×	34	1.6k
Hudie Wei China	14	550 0.9×	835 1.8×	220 1.1×	142 0.9×	211 1.5×	31	1.5k
Ming Poi United States	20	415 0.7×	621 1.3×	145 0.7×	156 1.0×	60 0.4×	64	1.2k
Roger Strair United States	21	422 0.7×	783 1.7×	209 1.0×	97 0.6×	203 1.5×	68	1.6k

Countries citing papers authored by Christopher Twelves

Since Specialization

Citations

This map shows the geographic impact of Christopher Twelves's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Christopher Twelves with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Christopher Twelves more than expected).

Fields of papers citing papers by Christopher Twelves

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Christopher Twelves. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Christopher Twelves. The network helps show where Christopher Twelves may publish in the future.

Co-authorship network of co-authors of Christopher Twelves

This figure shows the co-authorship network connecting the top 25 collaborators of Christopher Twelves. A scholar is included among the top collaborators of Christopher Twelves based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Christopher Twelves. Christopher Twelves is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Rampling, R., Paul Mulholland, Allan James, et al.. (2016). A Cancer Research UK First Time in Human Phase I Trial of IMA950 (Novel Multipeptide Therapeutic Vaccine) in Patients with Newly Diagnosed Glioblastoma. Clinical Cancer Research. 22(19). 4776–4785. 122 indexed citations

Gregory, Walter M., Christopher Twelves, Richard H. Bell, et al.. (2016). Characterizing and quantifying the effects of breast cancer therapy using mathematical modeling. Breast Cancer Research and Treatment. 155(2). 303–311. 3 indexed citations

Braunstein, Marsela, Linda M. Liao, Karen J. Taylor, et al.. (2016). Downregulation of histone H2A and H2B pathways is associated with anthracycline sensitivity in breast cancer. Breast Cancer Research. 18(1). 16–16. 20 indexed citations

Twelves, Christopher, Javier Cortés, Peter A. Kaufman, et al.. (2015). “New” metastases are associated with a poorer prognosis than growth of pre-existing metastases in patients with metastatic breast cancer treated with chemotherapy. Breast Cancer Research. 17(1). 150–150. 33 indexed citations

Abraham, Jean, Louise Hiller, Leila Dorling, et al.. (2015). A nested cohort study of 6,248 early breast cancer patients treated in neoadjuvant and adjuvant chemotherapy trials investigating the prognostic value of chemotherapy-related toxicities. BMC Medicine. 13(1). 306–306. 25 indexed citations

Gradishar, William J., Christopher Twelves, & Hope S. Rugo. (2014). Evidence-driven, patient-specific approaches for optimizing survival prolongation in breast cancer.. PubMed. 12(8 Suppl 15). 3–21; quiz 22. 1 indexed citations

Brown, Sarah, Walter M. Gregory, Christopher Twelves, & Julia Brown. (2014). A Practical Guide to Designing Phase II Trials in Oncology. Medical Entomology and Zoology. 4 indexed citations

McCleary, Nadine J., Jeffrey A. Meyerhardt, Erin Green, et al.. (2013). Impact of Age on the Efficacy of Newer Adjuvant Therapies in Patients With Stage II/III Colon Cancer: Findings From the ACCENT Database. Journal of Clinical Oncology. 31(20). 2600–2606. 157 indexed citations

Munro, Alison F., Eva Balslev, Christopher Twelves, et al.. (2013). Is TIMP-1 immunoreactivity alone or in combination with other markers a predictor of benefit from anthracyclines in the BR9601 adjuvant breast cancer chemotherapy trial?. Breast Cancer Research. 15(2). R31–R31. 3 indexed citations

10.

Ali, Alaa M., Elena Provenzano, John M.S. Bartlett, et al.. (2013). Prognosis of early breast cancer by immunohistochemistry defined intrinsic sub-types in patients treated with adjuvant chemotherapy in the NEAT/BR9601 trial. International Journal of Cancer. 133(6). 1470–1478. 13 indexed citations

11.

Anthoney, Alan, Jay Naik, Iain R. Macpherson, et al.. (2012). Phase I study of TP300 in patients with advanced solid tumors with pharmacokinetic, pharmacogenetic and pharmacodynamic analyses. BMC Cancer. 12(1). 536–536. 8 indexed citations

12.

Perez, Edith A., Susan L. Mooberry, Christopher Twelves, & Hope S. Rugo. (2011). New frontiers and treatment paradigms for metastatic breast cancer. A Review of an adjunct symposium of the 2011 American Society of Clinical Oncology Annual Meeting, June 4, 2011 Chicago, Illinois.. PubMed. 9(8 Suppl 20). 1–15. 3 indexed citations

13.

Massard, Christophe, Jean‐Charles Soria, Alan Anthoney, et al.. (2011). A first in man, phase I dose-escalation study of PHA-793887, an inhibitor of multiple cyclin-dependent kinases (CDK2, 1 and 4) reveals unexpected hepatotoxicity in patients with solid tumors. Cell Cycle. 10(6). 963–970. 44 indexed citations

14.

Menis, Jessica & Christopher Twelves. (2011). Eribulin (Halaven): a new, effective treatment for women with heavily pretreated metastatic breast cancer. Breast Cancer Targets and Therapy. 3. 101–101. 21 indexed citations

15.

Faratian, Dana, Alison F. Munro, Christopher Twelves, & John M.S. Bartlett. (2009). Membranous and cytoplasmic staining of Ki67 is associated with HER2 and ER status in invasive breast carcinoma. Histopathology. 54(2). 254–257. 55 indexed citations

16.

Mackay, Helen & Christopher Twelves. (2007). Targeting the protein kinase C family: are we there yet?. Nature reviews. Cancer. 7(7). 554–562. 308 indexed citations

17.

Jones, Robert J. & Christopher Twelves. (2002). Pemetrexed: a multitargeted antifolate (ALIMTA™, LY-231514). Expert Review of Anticancer Therapy. 2(1). 13–22. 12 indexed citations

18.

Lowry, Martin, et al.. (1992). Visibility of phospholipids in ³¹P NMR spectra of human breast tumours in vivo. NMR in Biomedicine. 5(1). 37–42. 16 indexed citations

19.

Twelves, Christopher, et al.. (1989). Haematological recovery following high-dose cyclophosphamide with autologous bone marrow transplantation. Cancer Chemotherapy and Pharmacology. 25(3). 213–218. 2 indexed citations

20.

Harrison, Nicholas K., Christopher Twelves, Bruce Addis, et al.. (1988). Peripheral T-Cell Lymphoma Presenting with Angioedema and Diffuse Pulmonary Infiltrates. American Review of Respiratory Disease. 138(4). 976–980. 10 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact